These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 24403237

  • 1. A population-based comparison of second primary cancers in Germany and Sweden between 1997 and 2006: clinical implications and etiologic aspects.
    Liu H, Hemminki K, Sundquist J, Holleczek B, Katalinic A, Emrich K, Jansen L, Brenner H, GEKID Cancer Survival Working Group.
    Cancer Med; 2013 Oct; 2(5):718-24. PubMed ID: 24403237
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Second primary cancers after cancer of unknown primary in Sweden and Germany: efficacy of the modern work-up.
    Liu H, Hemminki K, Sundquist J, Holleczek B, Katalinic A, Emrich K, Brenner H, GEKID Cancer Survival Working Group.
    Eur J Cancer Prev; 2013 May; 22(3):210-4. PubMed ID: 22960777
    [Abstract] [Full Text] [Related]

  • 4. Risk of second primary cancers in women diagnosed with endometrial cancer in German and Swedish cancer registries.
    Chen T, Brenner H, Fallah M, Jansen L, Castro FA, Geiss K, Holleczek B, Katalinic A, Luttmann S, Sundquist K, Ressing M, Xu L, Hemminki K, GEKID Cancer Survival Working Group+.
    Int J Cancer; 2017 Dec 01; 141(11):2270-2280. PubMed ID: 28815572
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Risk of Second Primary Cancers in Multiple Myeloma Survivors in German and Swedish Cancer Registries.
    Chen T, Fallah M, Brenner H, Jansen L, Mai EK, Castro FA, Katalinic A, Emrich K, Holleczek B, Geiss K, Eberle A, Sundquist K, Hemminki K, GEKID Cancer Survival Working Group.
    Sci Rep; 2016 Feb 24; 6():22084. PubMed ID: 26908235
    [Abstract] [Full Text] [Related]

  • 7. Second cancers and causes of death in patients with testicular cancer in Sweden.
    Zhang L, Hemminki O, Chen T, Yu H, Zheng G, Chattopadhyay S, Försti A, Sundquist K, Sundquist J, Hemminki K.
    PLoS One; 2019 Feb 24; 14(3):e0214410. PubMed ID: 30921367
    [Abstract] [Full Text] [Related]

  • 8. Bladder and upper urinary tract cancers as first and second primary cancers.
    Zheng G, Sundquist K, Sundquist J, Försti A, Hemminki O, Hemminki K.
    Cancer Rep (Hoboken); 2021 Dec 24; 4(6):e1406. PubMed ID: 34114732
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Risk of second primary cancer among patients with head and neck cancers: A pooled analysis of 13 cancer registries.
    Chuang SC, Scelo G, Tonita JM, Tamaro S, Jonasson JG, Kliewer EV, Hemminki K, Weiderpass E, Pukkala E, Tracey E, Friis S, Pompe-Kirn V, Brewster DH, Martos C, Chia KS, Boffetta P, Brennan P, Hashibe M.
    Int J Cancer; 2008 Nov 15; 123(10):2390-6. PubMed ID: 18729183
    [Abstract] [Full Text] [Related]

  • 12. Second primary neoplasms among 53 159 haematolymphoproliferative malignancy patients in Sweden, 1958-1996: a search for common mechanisms.
    Dong C, Hemminki K.
    Br J Cancer; 2001 Sep 28; 85(7):997-1005. PubMed ID: 11592772
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Second Primary Cancers in Patients with Invasive and In Situ Squamous Cell Skin Carcinoma, Kaposi Sarcoma, and Merkel Cell Carcinoma: Role for Immune Mechanisms?
    Chattopadhyay S, Hemminki A, Försti A, Sundquist K, Sundquist J, Hemminki K.
    J Invest Dermatol; 2020 Jan 28; 140(1):48-55.e1. PubMed ID: 31288011
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Rate differences between first and second primary cancers may outline immune dysfunction as a key risk factor.
    Zheng G, Sundquist K, Sundquist J, Försti A, Hemminki A, Hemminki K.
    Cancer Med; 2020 Nov 28; 9(21):8258-8265. PubMed ID: 32960498
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.